Enrolment of racial minorities across 15 years of multiple myeloma randomised trials; calling on researchers to become agents of change

Lancet Haematol. 2020 Oct;7(10):e704-e706. doi: 10.1016/S2352-3026(20)30281-7. Epub 2020 Sep 1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Minority Groups
  • Multiple Myeloma / epidemiology*
  • Multiple Myeloma / therapy
  • Patient Selection
  • Race Factors
  • Racial Groups
  • Randomized Controlled Trials as Topic